ARQT
Arcutis Biotherapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -12.5% ·
Aktienfluss +2.4% ·
neue Nettopositionen -14.3%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +8 | 69.46M | $1.82B | +11 | −2 |
| Q1 2026 | 99 | +1 | 69.94M | $1.65B | +6 | −6 |
| Q4 2025 | 97 | +2 | 70.50M | $2.05B | +3 | — |
| Q3 2025 | 16 | 0 | 32.55M | $613.65M | +1 | −2 |
| Q2 2025 | 14 | -2 | 28.30M | $396.73M | — | −2 |
| Q1 2025 | 13 | 0 | 11.91M | $186.25M | +1 | −1 |
| Q4 2024 | 13 | +1 | 15.11M | $210.56M | +1 | — |
| Q3 2024 | 11 | +1 | 9.54M | $88.77M | +2 | −1 |
| Q2 2024 | 10 | — | 8.25M | $76.75M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passiv) | 8.53M | — | $119.63M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passiv) | 7.05M | — | $98.83M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passiv) | 7.05M | — | $98.83M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passiv) | 7.05M | — | $98.83M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passiv) | 7.05M | — | $98.83M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passiv) | 7.05M | — | $98.83M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (passiv) | 4.53M | +1.2% | $63.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Geode Capital Management ✦ (passiv) | 2.58M | +1.4% | $36.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passiv) | 2.58M | +1.4% | $36.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 2.16M | +8.7% | $30.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 2.16M | +8.7% | $30.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Point72 Asset Management ✦ | 1.49M | +78.9% | $20.83M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 27 | Millennium Management ✦ | 910.84K | +92.3% | $12.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 375.23K | +51.2% | $5.26M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 375.23K | +51.2% | $5.26M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 375.23K | +51.2% | $5.26M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 375.23K | +51.2% | $5.26M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 375.23K | +51.2% | $5.26M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Norges Bank ✦ (passiv) | 174.82K | -74.3% | $2.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 150.73K | — | $2.11M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 150.73K | — | $2.11M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Citadel Advisors ✦ | 145.49K | -53.1% | $2.04M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 84.05K | +7.8% | $1.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Two Sigma Investments ✦ | 71.68K | -52.7% | $1.00M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 44.27K | -5.1% | $620,622 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Wellington Management ✦ | 44.27K | -5.1% | $620,622 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Wellington Management ✦ | 44.27K | -5.1% | $620,622 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | Wellington Management ✦ | 44.27K | -5.1% | $620,622 | 0.0% | ▼ Trim | 5 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Marshall Wace | $905,681 | war 0.0% |
| Renaissance Technologies | $340,936 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 267 Inhaber, 132.09M Anteile, $3.07B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Director · 1.07K Ant. · $27,912
Officer · 1.70K Ant. · $45,819
Director · 4.73K Ant. · $123,835
Officer · 6.70K Ant. · $174,767
Officer · 8.30K Ant. · $220,129
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik